Clinical trial Recruiting at 1 site Phase 3 Interventional Ages 18 to 70

Toothpaste for reducing dental plaque and preventing gum problems

Official title: Clinical Evaluation of a Stannous Fluoride Toothpaste Versus a 67% Bicarbonate Toothpaste and Colgate Cavity Protection Toothpaste for Dental Plaque Reduction and Prevention of Gum Problems: a Six-month Clinical Study in Italy

Run by Colgate Palmolive · NCT07842991 · Data updated 2026-11-12

This study tests three toothpaste options to see if they reduce plaque and gingivitis in adults with mild gum inflammation.

Quick facts

PhasePhase 3
Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment120 (estimated)
SponsorColgate Palmolive
Industry-sponsored
Locations1 site (Roma, Rome)
StatusRecruiting
StartedJuly 20, 2026
Main results expectedJanuary 2027
Study endsJanuary 2027
Registry record updatedSeptember 25, 2026
Trial IDNCT07842991 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18-70 in good general health with initial gingivitis and plaque scores of at least 1.5 each and the ability to commit to six months of follow-up.

Probably not a fit

Individuals with advanced periodontal disease, extensive tooth loss, recent antibiotic use, or other exclusions may not experience benefit from these toothpaste regimens.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this Phase 3 interventional trial, eligible adults aged 18-70 with baseline gingivitis and plaque scores are randomized to three toothpaste regimens and instructed to use them as directed. Participants will be evaluated at 3 and 6 months for changes in gingivitis and plaque and monitored for adverse events. The trial is conducted at a single site in Rome with Colgate-Palmolive as the lead sponsor. Safety and effectiveness data will inform whether the products can reduce gum inflammation and plaque formation compared with standard care. Enrollment requires informed consent and compliance with study visits over six months.

Why it matters

Potential benefit: If successful, participants may experience reduced plaque and gingival inflammation with the tested toothpastes.

How similar studies have gone: Previous studies have explored toothpaste formulations for plaque and gingivitis; results have varied by formulation, making this evaluation valuable for comparative effectiveness.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Subjects, ages 18-70, inclusive.
* Availability for the six-month duration of the study.
* Good general health.
* Initial gingivitis index of at least 1.5 as determined by the use of the Modified Gingivitis Index.
* Initial plaque index of at least 1.5 as determined by the use of the Modified Quigley-Hein Plaque Index.
* Signed Informed Consent Form

Exclusion Criteria:

* Orthodontic bands.
* Tumor(s) of the soft or hard tissues of the oral cavity.
* Advanced periodontal disease (purulent exudate, tooth mobility), and/or
* Extensive loss of periodontal attachment or alveolar bone.
* Five or more carious lesions requiring immediate restorative treatment
* Use of antibiotics any time during the one month prior to entry into the study.
* Participation in any other clinical study or test panel within the one month prior to entry into the study.
* Received a dental prophylaxis in the two weeks prior to your initial examination.
* History of allergies to oral care/personal care consumer products or their ingredients.
* Having taken any prescription medicines that might interfere with the study outcome.
* If you with an existing medical condition which prohibits you from not eating or drinking for periods of up to 4 hours.
* Self-reported pregnant or breast feeding an infant.
* History of drug abuse

Where it's running

  • Clinica Odontoiatrica Montesani
    Roma, Rome, Italy
    Recruiting

Study contacts

  • Principal investigator: Luigi Montensani, DDS — Clinica Odontoiatrica Montesani
  • Study coordinator: Luigi Montensani, DDS
  • Email: luigi@montensani.it
  • Phone: +39-338-6187383;

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.